Market Research Report
Wound Care Markets (Skin Ulcer Treatment, Burn Treatment, Hydrocolloids, Adhesives, Pressure Relief, Silver, Regenerative Products, Trauma Care, NPWT, Dressings, Tapes, Debridement, Collagen, Staples, Sutures and Other Devices)
|Published by||Kalorama Information||Product code||204409|
|Published||Content info||320 Pages
|Wound Care Markets (Skin Ulcer Treatment, Burn Treatment, Hydrocolloids, Adhesives, Pressure Relief, Silver, Regenerative Products, Trauma Care, NPWT, Dressings, Tapes, Debridement, Collagen, Staples, Sutures and Other Devices)|
|Published: December 15, 2016||Content info: 320 Pages||
The worldwide wound care market reached revenues of $20,980.7 million in 2016 based on sales at the manufacturers' level. The market is varied in terms of both product offerings and product maturity. Several of the products within the worldwide wound care market are mature such as anti-infectives and pressure relief devices, while others such as biological dressings and negative pressure wound therapy are in the growth stages of development. Thus, some products within the market are slowing in growth rates while others are driving growth.
Kalorama Information's Advanced Wound Care Markets Worldwide Provides useful information to business planners including market size estimates for various segments, forecasts, trend analysis, competitive analysis, corporate profiles, market share and other information. The worldwide wound care market is a technologically enriched environment dedicated to advancing wound care therapies. Overall, the industry is showing renewed signs of growth as the demand for products remains strong. Wound care is a balancing act due to the aging population and co-morbidity of diseases such as diabetes, cardiovascular disease, obesity and other diseases that present an ever-present challenge to wound care practitioners and manufacturers alike.
Skin ulcer wound treatment is a complex, intricate series of events influenced by internal and external conditions. Factors that influence the events of the wound-healing cascade are determined by deficiencies and comorbidities of the patient in addition to the environment of the wound. Treatments for skin ulcer wounds vary according to the type of wound and the individual needs of the wound but include the following categories:
Burn wound management consists of measures to limit bacterial infection in the wound and on adjacent tissue. The burn has left the body susceptible to serious infection. The first line of defense, the skin, has been destroyed by the burn injury. At first, burn wounds are sterile because of the heat that caused the burn, but bacterial flora soon re-establishes colonies on the burned skin or Escher. The medium is favorable for pathogenic growth because of the necrotic tissue and warm environment that exist within the burn wound dressing. Benign microorganisms normally found on the skin, in the gastrointestinal tract, and in the pulmonary system become lethal as they colonize the burn wound and invasive sepsis occurs. Burn recovery is long an with complications the rule rather than the exception. The report covers the following products in burn wound management:
Surgical Trauma and wound treatment influenced by internal and external conditions. Factors that influence the events of the wound-healing cascade are determined by deficiencies and comorbidities of the patient in addition to the environment of the wound. Treatments for surgical and traumas wounds vary according to the type of wound and the individual needs of the wound but include the following categories:
Given that we are experiencing a worldwide aging of the population, these co-morbid diseases will continue to influence wound care challenges. All of this is influenced by and dependent on reimbursement coverage since most patients are over 65 years of age. onventional, mature products continue to generate the majority of sales; however, their growth rate is slow and limited by the maturity of the product and the competition. Advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. The aging of the population and continued advances in biotechnology drive the wound care industry. As a result of the growing population of the elderly, healthcare systems are challenged to treat rising incidences of complex diseases and conditions. Patients are being moved through the hospital faster putting more pressure on caregivers across all care settings and increasing the need for more sophisticated means to care for these patients. Enjoying market success depends on several factors. Manufacturers must develop a formidable strategy, which involves matching internal capabilities with external opportunities. By choosing to implement such strategies, providers are able to achieve high levels of clinical success while controlling use and costs. Manufacturers are continuing to create well-rounded and advanced products to provide a wider variety of choices.
Among the companies profiled in this report are the following:
Another area driving growth is the negative pressure wound therapy. The market is expected to exhibit an overall steady growth rate due to the increasing elderly population, rising rate of disease such as diabetes and obesity, availability of new therapeutic techniques, and the recent focus on wound care products and prevention.
There have been many research advancements in the last decade. However, recently hese advancements are taking place on a daily basis with the most significant changes in the past 30 years. New developments are providing the health care arena of today with some truly sophisticated, highly effective wound care treatments. With respect to wound dressings, the focus has been more on their categories rather than on their functions. Recent discussions have surfaced in literature that take note of this situation. There is a decided move for a paradigm shift in decision making about dressings. The shift is described as the interactive and active use of dressing materials in the same way as drugs, with specific actions, interactions, contraindications, indications, and side effects.
The emerging generation of wound care products and technologies are well positioned to capitalize on this growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.
The worldwide wound care market is based on total manufacturers' revenues. The information and analysis presented in this report are based on extensive surveys of senior management in the wound care market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct over 100 face-to-face, telephone and email interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.
All market data pertains to the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year for data was 2016. Historical data are provided for each of the years 2014 through 2016, and forecast data are provided for each of the years 2016 through 2021. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2016 base year.
Other than that there are traditional factors. Aging of the population will have several varied effects on the healthcare industry as a whole, with specific implications for wound care. First, aging of the population will bring increased prevalence of chronic diseases-such as asthma, chronic obstructive pulmonary disorder (COPD), congestive heart failure (CHF), coronary heart disease (CHD), diabetes and osteoarthritis-which are more prevalent among the elderly. This will increase the need for wound care among the elderly population.
In addition, the elderly population itself is changing.
The global population above age 65 is expected to grow by 279% between 2000 and 2050. This growth is showing the fastest increase from 2040 through 2050 showing a progressive rise in the aging population.
In comparison, the total global population is expected to increase by 54% between 2000 and 2050 (6.1 billion to 9.4 billion).
Apps are another interesting. There are apps available everywhere for most everything and wound care is no exception. MoInlycke Healthcare launched an iPhone application for its Avance Negative Pressure Wound Therapy System. The app includes dressing application guides for the Avance system, access to customer services and details for ordering. The app can be downloaded on an iPhone, iPad or iPod Touch currently and the company is working on adding formats for other smartphones. Other companies are introducing their versions of apps for products in their line. It is expected that this application of technology will continue to grow in the future and become more common place in the industry.
Some examples of apps include the MOWA- Mobile Wound Analyzer - which is an application for advanced management of pressure injuries, diabetes and vascular disease. It is sophisticated and practical software for analyze images of ulcers and may also be useful as a reference manual and guide for post -visual evaluation. It is target to health professionals who heal wounds or want to learn how to heal wounds.
We are likely to see more apps in the future that are more intuitive and incorporate more assessment information.